Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Kwiterovich, P. O., Blumenthal, R. S., & Jones, S. R. (2013) · JAMA · doi:10.1001/jama.2013.280532 · Cited by 883 · see citing works

Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study

Hoogeveen, R. C., Gaubatz, J. W., Sun, W., Dodge, R. C., Crosby, J. R., Jiang, J., Couper, D., Virani, S. S., Kathiresan, S., Boerwinkle, E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303284 · Cited by 507 · see citing works

Atherogenic Lipoprotein Particles in Atherosclerosis

Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494 · see citing works

New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease

Tsai, M. Y., Steffen, B. T., Guan, W., McClelland, R. L., Warnick, R., McConnell, J. P., Hoefner, D. M., & Remaley, A. T. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302401 · Cited by 183 · see citing works

Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study

Arai, H., Kokubo, Y., Watanabe, M., Sawamura, T., Ito, Y., Minagawa, A., Okamura, T., & Miyamato, Y. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14936 · Cited by 134 · see citing works

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

Hoogeveen, R. C., & Ballantyne, C. M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa252 · Cited by 316 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study

Ikezaki, H., Lim, E., Cupples, L. A., Liu, C., Asztalos, B. F., & Schaefer, E. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019140 · Cited by 192 · see citing works

Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction

Varbo, A., & Nordestgaard, B. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab293 · Cited by 174 · see citing works

The dawn of a new era of targeted lipid-lowering therapies

Tokgözoğlu, L., & Libby, P. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab841 · Cited by 171 · see citing works

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies

Du, Z., & Qin, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12010363 · Cited by 140 · see citing works

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies

Jin, X., Yang, S., Lu, J., & Wu, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.804214 · Cited by 86 · see citing works

Triglycerides and cardiovascular disease

Esan, O., & Wierzbicki, A. S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000862 · Cited by 83 · see citing works

Small dense low-density lipoprotein particles: clinically relevant?

Krauss, R. M. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000824 · Cited by 63 · see citing works

Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with ‘Normal’ LDL-C Levels

Superko, H., & Garrett, B. (2022) · Biomedicines · doi:10.3390/biomedicines10040829 · Cited by 60 · see citing works

Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms

Hansen, S. E. J., Varbo, A., Nordestgaard, B. G., & Langsted, A. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad094 · Cited by 51 · see citing works

Update on apolipoprotein B

Sniderman, A. D., Langlois, M., & Cobbaert, C. M. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000754 · Cited by 49 · see citing works

Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project

Schaefer, E. J., Ikezaki, H., Diffenderfer, M. R., Lim, E., Liu, C., Hoogeveen, R. C., Guan, W., Tsai, M. Y., & Ballantyne, C. M. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.01.015 · Cited by 37 · see citing works

Small Dense Low‐Density Lipoprotein Cholesterol and Ischemic Stroke

Balling, M., Nordestgaard, B. G., Varbo, A., Langsted, A., Kamstrup, P. R., & Afzal, S. (2023) · Annals of Neurology · doi:10.1002/ana.26598 · Cited by 34 · see citing works

Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes

Hirano, T. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14398 · Cited by 31 · see citing works

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease

Ishii, J., Kashiwabara, K., Ozaki, Y., Takahashi, H., Kitagawa, F., Nishimura, H., Ishii, H., Iimuro, S., Kawai, H., Muramatsu, T., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63229 · Cited by 29 · see citing works

Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors

Masuda, R., Wist, J., Lodge, S., Kimhofer, T., Hunter, M. L., Hui, J., Beilby, J. P., Burnett, J. R., Dwivedi, G., Schlaich, M. P., et al. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.06.004 · Cited by 22 · see citing works

Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease

Koba, S., Satoh, N., Ito, Y., Yokota, Y., Tsunoda, F., Sakai, K., Nakamura, Y., Shoji, M., Hirano, T., & Shinke, T. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae061 · Cited by 20 · see citing works

Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation

Johannesen, C. D. L., Mortensen, M. B., Nordestgaard, B. G., & Langsted, A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119139 · Cited by 21 · see citing works

Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: The Multi-Ethnic Study of Atherosclerosis

Nomura, S. J. O., Karger, A. B., Garg, P. K., Cao, J., Bhatia, H. S., Duran, E. K., Duprez, D. A., Guan, W., & Tsai, M. Y. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100436 · Cited by 15 · see citing works

Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study

Sekimoto, T., Koba, S., Mori, H., Arai, T., Matsukawa, N., Sakai, R., Yokota, Y., Sato, S., Tanaka, H., Masaki, R., et al. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.04.008 · Cited by 15 · see citing works

Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study

Bilgic, S., Pencina, K. M., Pencina, M. J., Cole, J., Dufresne, L., Thanassoulis, G., & Sniderman, A. D. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321165 · Cited by 15 · see citing works

LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review

Akyol, Ö., Chiang, H., Burns, A. R., Yang, C.-Y., Woodside, D. G., Sawamura, T., Sánchez‐Quesada, J. L., Gotto, A. M., & Chen, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1649759 · Cited by 13 · see citing works

Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention

Sucato, V., Comparato, F., Ortello, A., Galassi, A. R., & Novo, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050460 · Cited by 12 · see citing works

Association between plasma maresin 1 and the risk of atherosclerotic cardiovascular disease in Chinese adults: A community-based cohort study

Li, M., Sun, Y., Liu, B., Xue, Y. Q., Zhu, M., Zhang, K., Yang, J., Ding, H., Liang, Y., Zhou, H., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.03.016 · Cited by 12 · see citing works

Estimated small dense low‐density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations

Huang, H., Xie, J., Hou, L., Miao, M., Xu, L., & Xu, C. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14133 · Cited by 11 · see citing works

Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction

Arai, T., Sekimoto, T., Koba, S., Mori, H., Matsukawa, N., Sakai, R., Yokota, Y., Sato, S., Tanaka, H., Masaki, R., et al. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.07.012 · Cited by 10 · see citing works

Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease

Yang, Q., Zou, Y., Lang, Y., Yang, J., Wu, Y., Xiao, X., Qin, C., Zhao, Y., & Liu, F. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2369701 · Cited by 9 · see citing works

Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by 1HNMR in children with familial hypercholesterolemia

Rodríguez-Borjabad, C., Narveud, I., Christensen, J. J., Ibarretxe, D., Andreychuk, N., Girona, J., Torvik, K., Folkedal, G., Bogsrud, M. P., Retterstøl, K., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.009 · Cited by 7 · see citing works

Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome

Klobučar, I., Habisch, H., Klobučar, L., Trbušić, M., Pregartner, G., Berghold, A., Kostner, G. M., Scharnagl, H., Madl, T., Frank, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095050 · Cited by 7 · see citing works

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib

Dunn, A., Ditmarsch, M., Kastelein, J. J. P., Kling, D. F., Neild, A. L., Davidson, M. H., & Gobburu, J. V. S. (2024) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2448 · Cited by 7 · see citing works

The association between small dense low-density lipoprotein cholesterol and peripheral artery disease: a large-scale cohort study and meta-analysis

Balling, M., Nordestgaard, B. G., Langsted, A., Varbo, A., Kamstrup, P. R., & Afzal, S. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf305 · Cited by 6 · see citing works

Clinical and lipid metabolic responses to diacylglycerol oil administration in Chinese adults with overweight/obesity or central obesity: a randomized, double-blind, placebo-controlled trial

Qin, L., Zhao, W. Z., Lin, Z., Bao, X., Li, R., Hao, Q., Yi, Z., Shen, Q., Jiang, H., Zhang, Y., et al. (2025) · Food & Function · doi:10.1039/d5fo02712h · Cited by 5 · see citing works

Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

Deza, S., Colina, I., Beloqui, Ó., Monreal, J. I., Martínez-Chávez, E., Maroto‐García, J., Mugueta, C., González, Á., & Varo, N. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117897 · Cited by 5 · see citing works

Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health

Blomquist, S. A., & Fernández, M. L. (2024) · Nutrients · doi:10.3390/nu16172941 · Cited by 5 · see citing works

Relationship between LDL-cholesterol, small and dense LDL particles, and mRNA expression in a cohort of African Americans

Diallo, A. F., Abbas, M., Goodney, G. A., Price, E. T., & Gaye, A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00332.2024 · Cited by 5 · see citing works

Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk

Bharadiya, V. M., Rawal, S., Jain, V., Chevli, P. A., & Mehta, A. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00702-1 · Cited by 4 · see citing works

Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease

Pencina, K. M., Pencina, M. J., Lawler, P. R., Engert, J. C., Dufresne, L., Ridker, P. M., Thanassoulis, G., Mora, S., & Sniderman, A. D. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac172 · Cited by 4 · see citing works

Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes

Grinshtein, Y. I., Шабалин, В. В., Ruf, R. R., Shalnova, S. A., & Drapkina, O. M. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3176 · Cited by 3 · see citing works

Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine

van der Laarse, A., & Cobbaert, C. M. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.2022475 · Cited by 3 · see citing works

Lipid Profile and Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome Patients: Relationships to Demographic, Clinical, Angiographic, and Therapeutic Variables

Pradhan, A. K., Kuka, R., Vishwakarma, P., Ali, W., Perrone, M. A., Iellamo, F., Chaudhary, G. K., Chandra, S., Sethi, R., Dwivedi, S. K., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226846 · Cited by 3 · see citing works

Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

Almutairi, A. R., Alshahrani, W. A., Alhathlol, G. K., Alsheikh, F., Alakeel, A., Yami, M. S. A., Fouda, M., Almohammed, O. A., Alhamed, M. S., Hafiz, A. M., et al. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102203 · Cited by 3 · see citing works

Non-HDL Cholesterol May Be Preferred over Apolipoprotein B-100 for Risk Assessment when Evaluated by Receiver Operator Characteristic Curve Analysis

Levinson, S. S. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae125 · Cited by 2 · see citing works

Elevated small dense low-density lipoprotein-cholesterol as a risk factor for lower extremity arterial disease in patients with type 2 diabetes mellitus

Zheng, D., & Cui, C. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109136 · Cited by 2 · see citing works

Exposure to a PFAS mixture alters cholesterol lipoprotein subfractions and induces a foam cell-like aortic macrophage expression profile in hyperlipidemic LDLr−/− mice

Roth, K., Yang, Z., Agarwal, M., Gurdziel, K., & Petriello, M. C. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117683 · Cited by 2 · see citing works

Association between PCSK9 inhibitor use and risk of incident heart failure in patients with dyslipidemia

Wu, J.-Y., Lee, K.-W., Huang, S.-C., Chang, H.-Y., & Lin, Y. (2026) · QJM · doi:10.1093/qjmed/hcag235 · Cited by 2 · see citing works

Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population

Zhang, T., Huang, S., Xie, P., Li, X., Pan, Y., Xu, Y., Han, P., Ding, F., Zhao, J., & Tang, H. D. (2022) · Disease Markers · doi:10.1155/2022/6030254 · Cited by 3 · see citing works

The world congress on insulin resistance, diabetes, and cardiovascular disease (WCIRDC)

Bloomgarden, Z. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13260 · Cited by 3 · see citing works

Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study

Saumoy, M., Sánchez‐Quesada, J. L., Assoumou, L., Gatell, J. M., Gonzalez‐Cordón, A., Guaraldi, G., Domingo, P., Giacomelli, A., Connault, J., Katlama, C., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac117 · Cited by 2 · see citing works

Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI

Zhao, D., Han, X., Mu, Q., Wu, Y., Shan, L., Su, L., Wang, W., Wang, P., Kang, Y., & Wang, F. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00828-6 · Cited by 1 · see citing works

Comparative Efficacy and Safety of Daily Versus Alternate-Day Dosing of Rosuvastatin in Diabetic Dyslipidemia: An Open-Label Clinical Trial

Kumari, N., Shamkuwar, C. A., Motghare, V. M., & Dakhale, G. N. (2025) · Cureus · doi:10.7759/cureus.85457 · Cited by 1 · see citing works

Level of medication non-adherence among ambulatory patients with dyslipidemia and comorbid illness in Northwest Ethiopia: a multicenter cross-sectional study

Moges, T. A., Dagnew, S. B., Anberbr, S. S., Bitew, B. E., Kiflu, M., Ferede, Y. A., Yiblet, T. G., & Zewdu, W. S. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251381590 · Cited by 1 · see citing works

Assessment of the relationship between AHR, sdLDL, Klotho biomarkers, and etiologic subtypes in young to middle-aged acute ischemic stroke according to toast classification

Chen, Z., Li, M., Xia, Y., Hou, S., Li, J., Wang, B., & Wang, Y. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08730-6 · Cited by 1 · see citing works

Does apolipoprotein B matter in the care of familial hypercholesterolemia?

Sniderman, A. D., & Watts, G. F. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.12.023 · Cited by 1 · see citing works

Value of IMA, IMAR, the IMA Index, and Other Hematological Features in Predicting AIS Caused by MCA Stenosis/Occlusion

Ren, B., Li, S., Chen, X., Yang, H., & Li, H. (2022) · Current Neurovascular Research · doi:10.2174/1567202619666220516145120 · Cited by 1 · see citing works

Predictive value of SII and sd-LDL for contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention

Shen, G., He, H., Wang, Z., Qiu, H., Zhu, Y., Zheng, D., Duan, Y., Lü, Y., & Li, W. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00114 · Cited by 1 · see citing works

Modern prospects of targeted hypolipidemic therapy

Kuchmin, A. N., Борисович, Н. М., Grachev, A. M., & Смирнова, Е. В. (2023) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma321350 · Cited by 1 · see citing works

Sex differences in the correlation between lipids related to cardiovascular risk factors and small dense LDL particles in patients with type 2 diabetes

Viktorínová, A., Brnka, R., Pirošová, M., Pontuch, P., & Kiňová, S. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2024-0069 · Cited by 1 · see citing works

Determination of Small and Dense of Low-Density Lipoprotein and Coronary Heart Disease

李, 国. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.118514

Clinical Utility of Small, Dense LDL as an Atherogenic Risk Marker

(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac132.199

Why Non-HDL Cholesterol is Preferred over Apolipoprotein B-100 (Apo B)Preprint

Levinson, S. S. (2023) · doi:10.32388/tulata

Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study

Zeenny, R. M., Abdo, R., Haddad, C., Hajj, A., Zeidan, R. K., Salameh, P., & Ferrières, J. (2024) · Pharmacy · doi:10.3390/pharmacy12060171

Exploring the impact of graded alcohol use on atherogenic lipid profiles among Latinos with underlying chronic liver disease

Patel, S. A., Bull, L. N., Baradaran-Salimi, K., Shui, A. M., Siao, K., Yang, B., Maher, J. J., & Khalili, M. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70010

Correlation Between the Arteriosclerosis Index of Plasma and Major Adverse Long-Term Prognosis in Patients with Coronary Artery Disease Combined with Stage 2–5 Chronic Kidney DiseasePreprint

Liu, H., Ren, J., Jiang, C., Shao, X., Zhao, J., & Chen, K. (2025) · Research Square · doi:10.21203/rs.3.rs-6800911/v1

The importance of collecting a family history of severe cardiovascular diseases in children with familial hypercholesterolemia and dyslipidemia of other origins: A retrospective study

Pupykina, V. V., & Zakharova, I. N. (2025) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2025.3.203414

Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment

Schwartz, G. G., Szarek, M. J., Cobbaert, C. M., Ruhaak, L. R., Schwertfeger, M., Bhatt, D. L., Bittner, V., Goodman, S. G., Harrington, R. A., Stevanovic, I., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101643

Lipid-related cardiovascular risk beyond low-density lipoprotein cholesterol

Balling, M., Hvid, K., Varbo, A., Langsted, A., Nordestgaard, B. G., & Afzal, S. (2026) · Heart · doi:10.1136/heartjnl-2025-326404

Epidemiological characteristics of serum small dense low-density lipoprotein cholesterol: From 2017 to 2019 in Chengdu adults, China

Li, J., Lv, Z., He, E., Wang, H., Wu, L., Wei, Y., Quan, H., & Zhang, S. (2026) · Medicine · doi:10.1097/md.0000000000048949

Association of small dense LDL cholesterol and inflammation with plaque rupture in acute coronary syndrome: An OCT study

Suzuki, K., Sekimoto, T., Koba, S., Arai, T., Mori, H., Sakai, K., Tanisawa, H., Sakai, R., Tanaka, H., Katagiri, M., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.007

Linking circulating chemerin and adiponectin to lipoprotein subclasses measured by 1H-NMR spectroscopy in 3199 participants from the study of health in Pomerania

Spindler, B., Hannemann, A., Völzke, H., Groß, S., Bahls, M., Budde, K., Petersmann, A., Henning, A., Winter, T., Könemann, S., et al. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02138-8

Correlation Between the Atherogenic Index of Plasma and Major Adverse Long-Term Prognosis in Patients With Coronary Artery Disease and Stage 2–5 Chronic Kidney Disease

Liu, H., Ren, J., Jiang, C., Shao, X., Zhao, J., & Chen, K. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48784

Comprehensive Evaluation of Atherosclerotic Cardiovascular Disease Risk Predictors Across the Pooled Cohort Equations, Predicting Risk of Cardiovascular Disease Events, and an Expanded Model

Zhang, Y., Schaefer, E. J., Ikezaki, H., Diffenderfer, M. R., Lloyd‐Jones, D. M., Hoogeveen, R. C., Ballantyne, C. M., DeFilippis, A. P., Guan, W., Tsai, M. Y., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.049726

Estimated Small Dense LDL Cholesterol and Coronary Artery Disease in Familial Hypercholesterolemia

Delialis, D., Rizos, C. V., Aivalioti, E., Moustou, C., Liamis, G. L., Skoumas, I., Sfikas, G., Kolovou, G. D., Rallidis, L. S., Garoufi, A., et al. (2026) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.66409

Small dense low-density lipoprotein particles: clinically relevant?

Krauss, R. M. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000824 · Cited by 63 · see citing works

Clinical Utility of Small, Dense LDL as an Atherogenic Risk Marker

(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac132.199

Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study

Arai, H., Kokubo, Y., Watanabe, M., Sawamura, T., Ito, Y., Minagawa, A., Okamura, T., & Miyamato, Y. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14936 · Cited by 134 · see citing works

Is Small Dense LDL a Highly Atherogenic Lipid or a Biomarker of Pro-Atherogenic Phenotype?

Meeusen, J. W. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab075 · Cited by 5 · see citing works

Small dense LDL cholesterol as strong predictors for secondary cardiovascular events compared with LDL cholesterol in elderly patients

Koba, S., Yokota, Y., Sakai, K., Nakamura, Y., Tsunoda, F., Shoji, M., Ito, Y., & Kobayashi, Y. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.562